LEXIVA (REMEDYREPACK INC.)
Welcome to the PulseAid listing for the LEXIVA drug offered from REMEDYREPACK INC.. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A4 Inducers [MoA],P-Glycoprotein Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | REMEDYREPACK INC. |
NON-PROPRIETARY NAME: | fosamprenavir calcium |
SUBSTANCE NAME: | FOSAMPRENAVIR CALCIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A4 Inducers [MoA],P-Glycoprotein Inducers [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2011-11-11 |
END MARKETING DATE: | 0000-00-00 |
LEXIVA HUMAN PRESCRIPTION DRUG Details:
Item Description | LEXIVA from REMEDYREPACK INC. |
LABELER NAME: | REMEDYREPACK INC. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 700(mg/1) |
START MARKETING DATE: | 2011-11-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49349-811_401a0d22-10e7-02ac-e054-00144ff88e88 |
PRODUCT NDC: | 49349-811 |
APPLICATION NUMBER: | NDA021548 |
Other FOSAMPRENAVIR CALCIUM Pharmaceutical Manufacturers / Labelers: